维普中文期刊产品整合服务
1183篇 您的检索式:作者名="FRIESS"
    题名 作者 年代 出处 被引量
1Different profiles of cytokine expression during mild and severe acute pancreatitis显示文摘AIM:To study secretion patterns of proand anti-in-flammatory cytokines, and activation of various cellular subsets of leukocytes in peripheral blood.METHODS: We have conducted a prospective obser-vational study. One hundred and eight patients with a diagnosis of acute pancreatitis and onset of the disease within last 72 h were included in this study. The mRNA expression of 25 different types of cytokines in white blood cells was determined by quantitative real time polymerase chain reaction. Levels of 8 different cytokines in blood serum were measured by enzymelinked immunosorbent assay. Clinical data and cytokine expression results were subjected to statistical analysis.RESULTS: Severe and necrotizing acute pancreatitis (AP) is characterized by the significant depletion of circulating lymphocytes. Severe acute pancreatitis is as-sociated with a typical systemic inflammatory response syndrome and over-expression of pro-inflammatory cy-tokines [interleukin (IL)-6, IL-8, macrophage migration inhibitory factor (MIF)]. Serum IL-6 and MIF concentra-tions are the best discriminators of severe and necrotiz-ing AP as well as possible fatal outcome during the early course of the disease. CONCLUSION: Deregulation of cellular immune sys-tem is a key event leading to severe and necrotizing AP. IL-6 and MIF could be used as early predictors of complications.Zilvinas Dambrauskas Nathalia Giese Antanas Gulbinas Thomas Giese Pascal O Berberat Juozas Pundzius Giedrius Barauskas Helmut Friess 2010World Journal of Gastroenterology2010,16,15:49
2预防性回肠造口在直肠癌超低位前切除术中的应用价值显示文摘目的探讨预防性回肠造口降低直肠癌超低位前切除术后吻合口瘘发生率的临床价值。方法回顾性分析8年间行直肠癌超低位前切除术98例患者的临床资料。比较实施预防性回肠造口组(A)45例和未实施组(B)53例两组间吻合口瘘发生率的差异。结果A组仅1例发生吻合口瘘(2.2%);B组11例发生吻合口瘘(20.8%)(P(0.05)。结论有选择的预防性回肠造口,可有效降低直肠癌超低位前切除术后吻合口瘘的发生率。阎玉矿 Helmut Friess Jrg Kleeff 2007中国普通外科杂志2007,16,4:20
3KAI1 gene is differently expressed in papillary and pancreatic cancer:influence on metastasis显示文摘AIM To compare KAI1 in cancer of papilla ofVater and pancreas to evaluate whether there aredifferences in biologic behavior which mightaccount for prognosis.METHODS We compared the expression in 24papillay and 29 pancreatic cancers usingNorthern blot analysis,immunochemical assayand in situ hybridization,and investigatedwhether early diagnosis or molecular differencespredict the outcome in these tumor entities.RESULTS By Northern blot analysis there is nostatistical difference of KAI1 levels in normaland cancerous papilla.No association betweenKAI1 mRNA expression and tumor stage or tumordifferentiation was found in the tumors.Byimmunohistochemical assay,KAI1 staining incytoplasm of papillary cancer cells was similarto that of normal papillary cells.By in situhybridization,the results of KAI1 mRNAexpression in normal and cancerous papilla weresimilar to those with immunohistochemicalassay.The normal and cancerous pancreastissues were also analyzed by the methods usedin papillary samples.CONCLUSION Although the biologic roles of KAI1 have not been clarified, our results suggest that KAI1 may restrict the progression of malignant papillary cancer, but its expression might not have any effect on the characteristics of papillary tumor, whereas by the analysis of KAl1 gene, its reduced expression is closely related to the progression and metastases of pancreatic cancer.Helmut Friess Markus W.Buchler 2000World Journal of Gastroenterology2000,6,6:20
4胰腺癌细胞起源和演进的新实验证据显示文摘目的大量研究证实导管样复合体就是胰腺癌的前体病变,因此,本研究旨在探索植入致癌剂后胰腺癌前体病变的产生和发展。方法采用手术方法将致癌剂DMBA植入SD大鼠胰腺,从第1天开始,在不同的时间点获取胰腺进行组织学研究,同时,分别以糜蛋白酶和细胞角蛋白作为胰腺腺泡细胞和导管细胞的标记物,通过免疫组化方法进行定位。结果在包埋致癌剂第2天就可以观察到正常胰腺小叶向导管复合体移型的现象,第4天出现典型的导管复合体,同时,胰岛也参与了这一过程。小叶中的非导管细胞迅速转分化为导管细胞的特征。在1个月时观察到导管腺癌的形成。与对照组相比,腺泡-导管转分化过程在DMBA包埋组持续存在。结论胰腺癌前体病变(导管复合体)除了由已经存在于小叶内的导管细胞组成外,主要通过腺泡细胞转分化形成,同时,胰岛细胞在某种程度上也参与了导管复合体的形成。因此,胰腺腺泡细胞、胰岛细胞和导管细胞共同参与了胰腺导管腺癌前体细胞的起源,转分化可以不需要细胞分裂迅速发生,而恶性转化需要较长的时间。郭俊超 赵玉沛 Dale E.Bockman 廖泉 Michael W.Muller Helmut Friess 2005中华肝胆外科杂志2005,11,5:12
5胰腺癌细胞对5-氟尿嘧啶和健择产生获得性耐药的分子生物学机制初探显示文摘目的 探索胰腺癌细胞对 5 氟尿嘧啶 ( 5 FU)和健择产生获得性耐药的机制 ,分析这种耐药与凋亡的调控基因———bcl 2家族之间的关系。方法 5 FU和健择的细胞毒性作用通过磺酰罗丹明B蛋白染色法 (SRB)来检测 ,应用RNA酶保护分析法来检测化疗药物作用前后bcl 2家族mRNA表达水平。结果 5 FU和健择对 3株胰腺癌细胞均产生了细胞毒性作用 ,5 FU长期作用后 ,Capan 1细胞 5 0 %抑制浓度 (IC50 )上升了 2 .1倍 (P <0 .0 5 )。健择长期作用后 ,Capan 1细胞IC50 上升了 1.8倍 (P <0 .0 5 )。RNA酶保护分析结果提示 ,bcl xL 和mcl 1上调的细胞产生了获得性耐药。结论 化疗药物长期作用后 ,抑凋亡基因bcl xL 和mcl 1上调 ,胰腺癌细胞产生了获得性耐药。阻断这些抑凋亡基因的表达可能提高胰腺癌细胞对 5 FU和健择的敏感性 ,从而产生治疗作用。石欣 裴斐 高乃荣 霍明东 胡浩霖 Friess Helmut 2003中华实验外科杂志2003,20,4:9
6Pain sensation in pancreatic diseases is not uniform: The different facets of pancreatic pain显示文摘AIM: To systematically characterize specific pain patterns in the most frequent pancreatic diseases.METHODS: Pain in patients with chronic pancreatitis(n = 314), pancreatic cancer(n = 469), and other pancreatic tumors(n = 249) including mucinous(n = 20) and serous cystadenoma(n = 31), invasive(n = 37) and non-invasive intraductal papillary mucinous neoplasia(IPMN; n = 48), low stage(n = 18) and high stage neuroendocrine neoplasia(n = 44), and ampullary cancer(n = 51) was registered and correlated with clinicopathological data. Survival times were estimated by the Kaplan-Meier method. Patients alive at the follow-up time were censored. Survival curves were compared statistically using the log-rank test.RESULTS: Forty-nine point one percent of pancreatic cancer patients revealed no pain, whereas in chronic pancreatitis only 18.3% were pain free. In contrary, moderate/severe pain was registered in 15.1% in pancreatic cancer patients that was increased in chronic pancreatitis with up to 34.2%. Serous cystadenoma was asymptomatic in most cases(58.1%), whereas 78.9% of all mucinous cystadenoma patients suffered pain. In neuroendocrine neoplasia pain was not a key clinical symptom since 64% of low stage neuroendocrine neoplasia and 59% of high stage neuroendocrine neoplasia patients were pain free. Cancer localization in the pancreatic body and patients with malignant pancreatic neoplasms were associated with more severe pain. Tumor grading and stage did not show any impact on pain. Only in pancreatic cancer, pain was directly associated with impaired survival.CONCLUSION: Pancreatic pain depicts different patterns of abdominal pain sensation according to the respective pancreatic disorder and does not allow a unification of the term pancreatic pain.Jan G D'Haese Mark Hartel Ihsan Ekin Demir Ulf Hinz Frank Bergmann Markus W Büchler Helmut Friess Güralp O Ceyhan 2014World Journal of Gastroenterology2014,20,27:8
7神经激肽-1受体在溃疡性结肠炎黏膜中的表达显示文摘目的 了解神经激肽 1受体 (NK 1R)在溃疡性结肠炎 (UC)病人结肠活检黏膜中的表达 ,探讨该受体的表达与UC严重程度的关系。方法 38个UC黏膜标本取自因该病而行结肠镜检查的病人 ,男 2 3例 ,女 15例 ;对照组结肠黏膜取自 15例肠易激综合征 (IBS)病人 ,男 8例 ,女 7例。应用逆转录聚合酶链反应 (RT PCR)检测对照组和UC肠黏膜NK 1R的mRNA表达水平 ,应用Westernblot技术检测NK 1R的蛋白水平 ,以免疫组化方法进行NK 1R的组织学定位。结果 与对照组肠黏膜相比 ,UC黏膜中NK 1RmRNA和蛋白都过度表达 ,NK 1RmRNA的表达与疾病的严重程度相关。免疫组化检查显示 ,NK 1R的表达主要位于UC的肠黏膜表面、黏膜固有层的单核细胞、黏膜下层的动静脉等处。结论 UC黏膜组织中NK 1R的表达水平明显上调 ,扰乱了神经激肽的作用环节 ,加剧了肠黏膜的病理改变。石欣 高乃荣 刘顺英 霍明东 胡浩霖 汤文浩 Helmut Friess 2003中华消化杂志2003,23,9:6
8Ruptured angiosarcoma of the liver treated by emergency catheter-directed embolization显示文摘血管肉瘤是有差的预后的肝的一个稀罕的主要的恶意的瘤。这里,我们与被紧急情况对待的一个破裂的肝的血管肉瘤报导一个病人的一个案例指导导管的 embolization,由左边的偏身出汗列在后面。Christine Leowardi Yura Hormann UIf Hinz Moritz N Wente Peter Hallscheidt Christa Flechtenmacher Markus W Büchler Helmut Friess Matthias HM Schwarzbach 2006World Journal of Gastroenterology2006,12,5:4
9P物质及其受体在胰腺癌细胞中的表达显示文摘目的 了解P物质(SP)、神经激肽-1受体(NK-1R)及中性肽链内切酶(NEP)在胰腺癌细胞中表达。方法应用实时定量逆转录-聚合酶链反应(RQ-RT-PCR)技术,检测正常胰腺、胰腺癌组织和7株胰腺癌细胞中前速激肽原A(PPT-A)、NK-1R和NEP的mRNA表达,应用Westernblot检测NK-1R和NEP的蛋白水平。结果正常胰腺组织PPT-A的mRNA表达水平为0.430 0±0.464 7,胰腺癌组织中为1.790 0±1.833 1(P<0.05);正常胰腺NK-1R的mRNA表达水平为0.088 2±0.086 8,胰腺癌组织中为2.154 5±2.103 1(P<0.01);正常胰腺组织NEP的mRNA表达水平为3.234 7±6.301 0,胰腺癌为8.606 9±8.703 2(P>0.05)。Western Blot结果发现,胰腺癌组织中NK-1R蛋白也过度表达,而NEP的蛋白水平未相应上调。结论 胰腺癌组织中SP和NK-1R都明显上调,而SP的降解酶——NEP未相应上调,这表明胰腺癌组织中SP的产生与灭活的平衡被打破,产生过多的SP,发挥过度的生物学效应。石欣 裴斐 高乃荣 Friess Helmut Kleeff Jorg Buchler Markus 2003中华实验外科杂志2003,20,2:4
10Basic thermoanalytical studies of insoluble collagen matrices显示文摘W. Friess G. Lee 1996Biomaterials1996,,23:3
11Surgical approaches for resection of pancreatic cancer: an overview显示文摘Objective: To overview the different surgical approach-es for the resection of pancreatic cancer and our expe-rience with these techniques.Methods: Surgical procedures including the Whipple re-section, pylorus-preserving resection, total and subto-tal panreatectomies, regional pancreatectomy and theextended lymph node resection were discussed.Results: Studies have shown that no operation seems toproduce significantly improved results in terms of sur-vival, mortality and resection rates compared to thestandard Whipple resection and pylorus-preservingduodenopancreatectomy.Conclusion: Despite the progress in the surgical treat-ment of pancreatic cancer, the overall prognosis afterresection remains unsatisfied. Surgery is likely to beoptional for the treatment of pancreatic cancer.Helmut Friess Jrg Kleeff Markus W Buchler 2002Hepatobiliary & Pancreatic Diseases International2002,1,1:3
12胰腺癌细胞株对氟尿嘧啶存在固有不敏感性显示文摘目的 研究胰腺癌细胞株是否对氟尿嘧啶 ( 5 - FU )具有固有或获得性不敏感。方法 用 SRB方法检测5 - FU对胰腺癌细胞株 As PC- 1、Capan- 1、Mia- Pa Ca- 2、Panc- 1和 T3 M4的毒性作用。结果 5 - FU对所有胰腺癌细胞株的 IC50 都很高 ,其中 Mia- Pa Ca- 2和 Panc- 1细胞株对 5 - FU最不敏感 ( IC50 =12 ,13 nmol/ L )。即使是在 5 - FU最敏感的 Capan- 1细胞株 ,其 IC50 仍相当高 ( 473 pm ol/ L)。这些细胞株对 5 - FU的 IC50 甚至高出其临床常用剂量给药时血浆药物浓度的 1~ 5 6倍。结论 大多数胰腺癌细胞株对 5 - FU固有不敏感 ,这些发现也许能作为临床上 5 -刘胜利 Helmut Friess Jorg Kleeff Markus W Bchler 2002中国药科大学学报2002,33,6:3
13Is laparoscopic colorectal cancer surgery equal to open surgery? An evidence based perspective显示文摘Laparoscopic colorectal surgery(LCS) is an evolving subject.Recent studies show that LCS can not only offer safe surgery but evidence is growing that this new technique can be superior to classical open procedures.Fewer perioperative complications and faster postoperative recovery are regularly mentioned when studies of LCS are presented.Even though the learning curve of LCS is frequently debated when limitations of laparoscopic surgeries are reviewed,studies show that in experienced hands LCS can be a safe procedure for colorectal cancer treatment.The learning curve however,is associated with high conversion rates and economical aspects such as higher costs and prolonged hospital stay.Nevertheless,laparoscopic colorectal cancer surgery(LCCR) offers several advantages such as less co-morbidity and less postoperative pain in comparison with open procedures.Furthermore,the good exposure of the pelvic cavity by laparoscopy and the magnification of anatomical structures seem to facilitate pelvic dissection laparoscopically.Moreover,recent studies describe no difference in safety and oncological radicalness in LCCR compared to the open total mesorectal excision(TME).The oncological adequacy of LCCR still remains unproven today,because long-term results do not yet exist.To date,only a few studies have described the results of laparoscopic TME combined with preoperative adjuvant treatment for colorectal cancer.The aim of this review is to examine the various areas of development and controversy of LCCR in comparison to the conventional open approach.Beat M Künzli Helmut Friess Shailesh V Shrikhande 2010World Journal of Gastrointestinal Surgery2010,2,4:3
14European experts consensus statement on cystic tumours of the pancreas显示文摘Marco Del Chiaro Caroline Verbeke Roberto Salvia Gunter Kl?ppel Jens Werner Colin McKay Helmut Friess Riccardo Manfredi Eric Van Cutsem Matthias L?hr Ralf Segersv?rd 2013Digestive and Liver Disease2013,,:3
15The Neurotrophic Factor Artemin Promotes Pancreatic Cancer Invasion显示文摘Güralp O. Ceyhan Nathalia A. Giese Mert Erkan Annika G. Kerscher Moritz N. Wente Thomas Giese Markus W. Büchler Helmut Friess 2006Annals of Surgery2006,,2:3
16Distal Pancreatectomy: Risk Factors for Surgical Failure in 302 Consecutive Cases显示文摘J?rg Kleeff Markus K. Diener Kaspar Z?graggen Ulf Hinz Markus Wagner Jeannine Bachmann J?rg Zehetner Michael W. Müller Helmut Friess Markus W. Büchler 2007Annals of Surgery2007,,4:3
17Mixed antagonist response and sepsis severity-dependent dysbalance of pro- and anti-inflammatory responses at the onset of postoperative sepsis显示文摘Alexander R. Novotny Daniel Reim Volker Assfalg Felicitas Altmayr Helmut M. Friess Klaus Emmanuel Bernhard Holzmann 2011Immunobiology2011,,6:3
18胰腺癌细胞对5氟脲嘧啶和健择的获得性耐药机制的研究显示文摘目的探讨胰腺癌细胞对 5氟脲嘧啶 (5 FU)和健择产生获得性耐药的机制。方法用磺酰罗丹明B蛋白染色法检测细胞毒性作用 ,根据药物剂量与细胞生存的关系计算 5 0 %抑制浓度(IC50 ) ;用RNA酶保护分析和Westernblot法来检测Bcl xL和mcl 1的表达水平。结果 5 FU和健择对 3株胰腺癌细胞均产生了细胞毒性作用。 5 FU长期作用后 ,Capan 1细胞IC50 上升了 2 1倍 (P <0 0 5 ) ;健择长期作用后 ,Capan 1细胞IC50 上升了 1 8倍 (P <0 0 5 ) ;而Mia Paca 2细胞在 5 FU和健择作用前后IC50 明显降低 (P <0 0 5 )。产生获得性耐药细胞的Bcl xL 和mcl 1的表达均上调。结论胰腺癌细胞对 5 FU相对耐药 ,而对健择较为敏感。化疗药物长期作用后 ,抑凋亡基因Bcl xL和mcl 1的表达上调 ,胰腺癌细胞产生了获得性耐药。石欣 高乃荣 霍明东 胡浩霖 Friess Helmut Kleeff Jorg Buchler Markus 2003中华普通外科杂志2003,18,1:3
19P物质及其受体在慢性胰腺炎组织的表达和临床意义显示文摘目的 了解P物质及其受体NK 1R在正常胰腺和慢性胰腺炎中的表达 ,探讨它们与慢性胰腺炎时疼痛发生的关系。方法 2 5个慢性胰腺炎标本取自慢性胰腺炎手术 ,男性 18例 ,女性 7例 ,正常胰腺组织取自 2 0个器官捐献者 ,男性 11例 ,女性 9例。应用实时定量逆转录聚合酶链反应(RT PCR)技术 ,检测正常胰腺和慢性胰腺炎组织P物质和NK 1R的mRNA水平 ,应用Westernblot技术检测NK 1R的蛋白水平 ,应用免疫组织化学方法进行NK 1R的组织学定位。将P物质及其受体NK 1RmRNA水平与疼痛的的程度、发作频率和病程进行分析 ,寻找其中的相关性。结果 与正常胰腺相比 ,慢性胰腺炎组织中P物质和NK 1RmRNA和蛋白都过度表达 ,NK 1RmRNA水平与疼痛的程度、发作频率和病程明显相关。免疫组化检查显示 ,NK 1R的表达主要位于胰腺腺泡、胰腺导管、神经纤维和炎性细胞。结论 慢性胰腺炎组织中P物质和NK 1R的表达水平都明显上调 ,扰乱了神经激肽的作用环节 ,NK 1R的过度表达与疼痛发生有关。石欣 高乃荣 霍明东 胡浩霖 Friess Helmut Buchler Markus 2003中华肝胆外科杂志2003,9,3:3
20激光微切和巢式逆转录聚合酶链反应联合检测单个肝细胞的基因表达显示文摘目的 探讨检测单个肝细胞基因表达的方法。方法应用激光微切的方法从冰冻切片上将单个肝细胞切下,提取总RNA,将RNA逆转录成cDNA,采用巢式逆转录聚合酶链反应(RT-PCR)检测mRNA的表达。结果在显微镜下用紫外激光微切机,将单个肝细胞成功切下,提取RNA后,逆转录成cDNA,巢式RT-PCR的扩增产物在琼脂糖凝胶上清晰可见,其表达与细胞数量成正比。结论联合应用激光微切和巢式RT-PCR可以检测单个肝细胞的基因表达。石欣 高乃荣 霍明东 胡浩霖 Friess Helmut Buchler Markus 2003中华肝脏病杂志2003,11,1:2
返回顶部 每页显示:
共60页 首页 上一页 第1页 下一页 末页 /60 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费